These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 23071161

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome.
    Tohyama M, Hashimoto K, Yasukawa M, Kimura H, Horikawa T, Nakajima K, Urano Y, Matsumoto K, Iijima M, Shear NH.
    Br J Dermatol; 2007 Nov; 157(5):934-40. PubMed ID: 17854362
    [Abstract] [Full Text] [Related]

  • 24. Reactivation of human herpesvirus (HHV) family members other than HHV-6 in drug-induced hypersensitivity syndrome.
    Seishima M, Yamanaka S, Fujisawa T, Tohyama M, Hashimoto K.
    Br J Dermatol; 2006 Aug; 155(2):344-9. PubMed ID: 16882173
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Possible involvement of autoimmunity in fulminant type 1 diabetes.
    Oikawa Y, Shimada A.
    Diabetol Int; 2020 Oct; 11(4):329-335. PubMed ID: 33088639
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Co-existing of Neuromyelitis Optica and Fulminant Type 1 Diabetes.
    Saheki T, Imachi H, Ibata T, Fukunaga K, Yoshioka Y, Kobayashi T, Sato S, Mizumoto K, Yoshimoto T, Lyu J, Dong T, Murao K.
    Intern Med; 2019 Jul 01; 58(13):1913-1916. PubMed ID: 30918186
    [Abstract] [Full Text] [Related]

  • 32. Fulminant type 1 diabetes: A comprehensive review of an autoimmune condition.
    Luo S, Ma X, Li X, Xie Z, Zhou Z.
    Diabetes Metab Res Rev; 2020 Sep 01; 36(6):e3317. PubMed ID: 32223049
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Effect of human leukocyte antigen class II genes on acute-onset and slow-onset type 1 diabetes in the Japanese population.
    Katahira M, Segawa S, Maeda H, Yasuda Y.
    Hum Immunol; 2010 Aug 01; 71(8):789-94. PubMed ID: 20510319
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Drug hypersensitivity: pharmacogenetics and clinical syndromes.
    Phillips EJ, Chung WH, Mockenhaupt M, Roujeau JC, Mallal SA.
    J Allergy Clin Immunol; 2011 Mar 01; 127(3 Suppl):S60-6. PubMed ID: 21354501
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Slowly progressing form of type 1 diabetes mellitus in children: genetic analysis compared with other forms of diabetes mellitus in Japanese children.
    Ohtsu S, Takubo N, Kazahari M, Nomoto K, Yokota F, Kikuchi N, Koike A, Matsuura N.
    Pediatr Diabetes; 2005 Dec 01; 6(4):221-9. PubMed ID: 16390391
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.